HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of tetrodotoxin and verapamil on abnormal ventricular activity at the late stage of experimental myocardial infarction in dogs].

Abstract
An in situ experimental study of the heart has demonstrated that verapamil++ (0.3 mg/kg), administered intravenously to dogs with complete transverse heart block one day after two-step occlusion of the left descending coronary artery either produced a 15-30% drop in the incidence of abnormal ventricular activity (AVA) in some experiments, or had no effect on the latter in others. Tetrodotoxin (3 micrograms/kg) produced a 20-44% drop in AVA in all experiments. Combined administration of 0.2 mg/kg verapamil++ and 2 micrograms/kg tetrodotoxin completely suppressed AVA. At an early phase of its development (5-10 hours after the occlusion of the left descending artery), AVA was completely suppressed both by 0.3 mg/kg verapamil and 3 micrograms/kg tetrodotoxin. Mechanisms of AVA and its progress following coronary-artery occlusion in dogs are discussed.
AuthorsE P Aniukhovskiĭ, T Ivanovich, G G Beloshapko, L V Rozenshtraukh
JournalKardiologiia (Kardiologiia) Vol. 29 Issue 5 Pg. 66-71 (May 1989) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleDeĭstvie tetrodotoksina i verapamila na abnorma'lnuiu aktivnos't zheludochkov v pozdneĭ stadii éksperimenta'lnogo infarkta miokarda.
PMID2770089 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Tetrodotoxin
  • Verapamil
Topics
  • Animals
  • Dogs
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Heart Block (drug therapy, etiology)
  • Heart Ventricles (drug effects)
  • Male
  • Myocardial Infarction (complications)
  • Tetrodotoxin (administration & dosage)
  • Time Factors
  • Verapamil (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: